Brief: CLS Gets SEK 22.4 Mln Through Exercise Of Warrants, Decides On Directed Issue
Nov 26 (Reuters) - Clinical Laserthermia Systems AB
CLSRb.ST :
* RECEIVES SEK 22.4 MILLION THROUGH THE EXERCISE OF WARRANTS
OF
SERIES TO 7 B AND DECIDES ON A DIRECTED ISSUE
* ONE WARRANT ENTITLED HOLDER TO SUBSCRIBE FOR ONE NEW
B-SHARE IN
CLS AT A SUBSCRIPTION PRICE OF SEK 3.68 PER SHARE
Source text: ID:nWkr1TpkKy
Further company coverage: CLSRb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: CLS Enters Research Agreement With U.S. National Cancer Institute
Sweden's CLS Q1 sales fall 72% after partner talks
Brief: Clinical Laserthermia Systems Q1 EBIT Sek 1.7 Mln
Brief: CLS Receives Order Worth SEK 23 Mln For Prism Business
Brief: CLS Expects To Achieve Positive Cash Flow From Q4 2026 To Q1 2028